tariquidar has been researched along with Epilepsy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Lange, EC; Eriksson, J; Koepp, M; Labots, M; Lammertsma, AA; Potschka, H; Rongen, M; Russmann, V; Schuit, R; Seeger, N; Syvänen, S; van Kooij, R; Verbeek, J; Voskuyl, RA; Windhorst, AD; Zellinger, C | 1 |
| Hughes, JR | 1 |
| Bauer, M; Karch, R; Kletter, K; Langer, O; Löscher, W; Müller, M; Neumann, F; Wagner, CC; Zeitlinger, M | 1 |
| de Lange, EC; Eriksson, J; Labots, M; Lammertsma, AA; Syvänen, S; Tagawa, Y; Voskuyl, RA; Windhorst, AD | 1 |
| Cucullo, L; Hossain, M; Janigro, D; Manders, T; Marchi, N; Rapp, E | 1 |
| Aronica, E; Edelbroek, PM; Gorter, JA; Redeker, S; van Schaik, R; van Vliet, EA; Voskuyl, RA; Wadman, WJ | 1 |
1 review(s) available for tariquidar and Epilepsy
| Article | Year |
|---|---|
One of the hottest topics in epileptology: ABC proteins. Their inhibition may be the future for patients with intractable seizures.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Drug Resistance, Multiple; Epilepsy; Humans; Polymorphism, Single Nucleotide; Quinolines | 2008 |
5 other study(ies) available for tariquidar and Epilepsy
| Article | Year |
|---|---|
[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Carbon Radioisotopes; Chronic Disease; Disease Models, Animal; Epilepsy; Female; Gene Expression Regulation; Kinetics; Male; Phenobarbital; Positron-Emission Tomography; Quinidine; Quinolines; Radiochemistry; Rats; Rats, Sprague-Dawley; Recurrence; Treatment Outcome | 2013 |
Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Calcium Channel Blockers; Drug Resistance, Multiple; Epilepsy; Humans; Image Processing, Computer-Assisted; Infusions, Intravenous; Male; Positron-Emission Tomography; Quinolines; Verapamil | 2010 |
Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Carbon Radioisotopes; Epilepsy; Flumazenil; Kainic Acid; Male; Positron-Emission Tomography; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2012 |
Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Topics: Anticonvulsants; Astrocytes; Blood-Brain Barrier; Brain; Cells, Cultured; Coculture Techniques; Diazepam; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Epilepsy; Humans; Models, Neurological; Permeability; Phenytoin; Quinolines; Shear Strength; Sucrose; Tritium | 2007 |
Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Epilepsy; Male; Phenytoin; Quinolines; Rats; Rats, Sprague-Dawley | 2007 |